Summary: GC Holding AG has appointed Dr Per Falk as the new CEO, marking a significant leadership transition as the company celebrates its 103rd anniversary. Falk, who has been on GC’s board for over two years and brings 25 years of pharmaceutical experience, aims to lead the company’s growth in the dental care industry.

Key Takeaways:

  • Dr Per Falk’s appointment as CEO strengthens GC’s corporate governance and leadership for future growth in the dental sector.
  • Falk’s extensive experience in the pharmaceutical industry and his established relationship with GC’s board position him to effectively lead the company’s global expansion.

GC Holding AG announced the appointment of Dr Per Falk as chief executive officer. According to Makoto Nakao, chairman of the board of directors, this decision strengthens GC’s corporate governance by establishing GC Holding as the group’s parent company and major shareholder.

Leadership Transition as GC Celebrates 103rd Anniversary

Founded in 1921 and led by the Nakao family for over 100 years, GC is now celebrating its 103rd anniversary. Falk’s appointment comes at a pivotal time for the company as it looks ahead to future growth.

Falk has been a member of GC’s board of directors for two and a half years. With 25 years of experience in the pharmaceutical industry, he joins GC from Ferring Pharmaceuticals, where he served as president.

“It is very fortunate for the GC Group and its shareholders that Dr Per Falk will take on the CEO responsibility. His professional experience and knowledge of GC business, combined with the trust of the Nakao family, place him in an ideal position to become CEO of the GC Group,” said Nakao.

Focus on Future Growth in Dental Care

Under the leadership of GC Holding AG, headquartered in Lucerne, Switzerland, GC plans to further develop its dental care offerings. Falk expressed his excitement for the opportunity, saying, “I look forward to working closely with our Chairman Mr. Nakao and all our skilled and dedicated colleagues to grow GC’s position as a strong contributor in the global dental and oral health sector.”